Skip to main content
Premium Trial:

Request an Annual Quote

Quantum-Si: Marijn Dekkers, Ruth Fattori

Single-molecular protein sequencing firm Quantum-Si has appointed Marijn Dekkers and Ruth Fattori to its board of directors. Both individuals have agreed to continue to serve on the board of the combined company subsequent to the closing of the previously announced business combination between Quantum-Si and HighCape Capital Acquisition.

Dekkers is founder and chairman of Novalis LifeSciences. From 2010 to 2016 he was CEO of Bayer AG, and from 2002 to 2009 he was CEO of Thermo Fisher Scientific. Dekkers currently serves on the board of directors for the Foundation for the National Institutes of Health, Georgetown University, Quanterix, and Cerevel Therapeutics.

Fattori is managing partner of Pecksland Partners. She also serves as a senior advisor at the Boston Consulting Group. Most recently, she was executive vice president and chief human resources officer of PepsiCo. She also previously served as executive VP and chief administrative officer for MetLife and chair of the MetLife Foundation.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.